Icahn School of Medicine at Mount Sinai ( Site 0004)

New York, New York 10029

0 studies enrolling now · 1 studies all time

What they study most

Merkel Cell Carcinoma

Studies at this site

• Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913) — Completed